These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G. Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843 [Abstract] [Full Text] [Related]
3. Proteinuria and renal tubular damage: urinary N-acetyl-beta-D-glucosaminidase and isoenzymes in dissimilar renal disease. Rustom R, Costigan M, Shenkin A, Bone JM. Am J Nephrol; 1998 Nov; 18(3):179-85. PubMed ID: 9627032 [Abstract] [Full Text] [Related]
4. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study. Navarro JF, Mora C, Muros M, Maca M, Garca J. Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807 [Abstract] [Full Text] [Related]
6. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Basturk T, Altuntaş Y, Kurklu A, Aydin L, Eren N, Unsal A. Ren Fail; 2006 Aug; 28(2):125-8. PubMed ID: 16538969 [Abstract] [Full Text] [Related]